NEXGEL Inc. (NXGL), a provider of medical and over-the-counter products, including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, expects revenue growth of over 100% in 2024 and is optimistic about its outlook for 2025.
The company has partnerships with STADA Arzneimittel AG, a European leader in consumer health; Cintas Corp, a provider of corporate identity uniforms, first aid and safety products, and services; and AbbVie Inc. (ABBV), among others.
For comments and feedback contact: editorial@rttnews.com
Economic News
What parts of the world are seeing the best (and worst) economic performances lately? Click here to check out our Econ Scorecard and find out! See up-to-the-moment rankings for the best and worst performers in GDP, unemployment rate, inflation and much more.
September 11, 2026 16:26 ET Consumer prices data was the main news on the economic front in the U.S. this week. In Europe, the latest interest rate decision from the European Central Bank was the focus along with the revised second quarter economic growth data for the euro area. In Asia, the monthly foreign trade data from China drew attention.